| Melissa Johnson, DPT | |
|
1776 W Centennial Pl, 2nd Floor, Addison, IL 60101-1075 | |
| (630) 953-0343 | |
| Not Available |
| Full Name | Melissa Johnson |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 17 Years |
| Location | 1776 W Centennial Pl, Addison, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558556431 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 070015982 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Athletico Ltd | 4789602681 | 1957 |
News Archive
Seattle scientists from Cure First, a non-profit research organization, and SEngine Precision Medicine, a biotech developing targeted, more effective, and less toxic cancer therapeutics, co-authored one of 27 high-profile papers published today by Cell Press.
Haloperidol is an effective first-line agent in combination with standard analgesic and antiemetic agents for the treatment of gastroparesis in the emergency department.
Two federal environmental standards regulating lead hazards in homes and child care facilities have different maximum thresholds, a discrepancy putting more than 35,000 kids in the United States at increased risk of lead poisoning.
Case Western Reserve University and Q2 Pharma Ltd., an Israeli biopharmaceutical company, have signed a two-year option to license small molecule, antivirulence technology to potentially treat bacterial infections such as methicillin-resistant staphylococcus aureus (MRSA), the first known scientific effort of its kind.
Monash University researchers have gained new insight into the early stages of our immune response, providing novel pathways to develop treatments for diseases from multiple sclerosis to cancer.
› Verified 7 days ago
| Provider Name | Accelerated Rehabilitation Centers Ltd |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1205875713 PECOS PAC ID: 2567372931 Enrollment ID: O20040224000455 |
News Archive
Seattle scientists from Cure First, a non-profit research organization, and SEngine Precision Medicine, a biotech developing targeted, more effective, and less toxic cancer therapeutics, co-authored one of 27 high-profile papers published today by Cell Press.
Haloperidol is an effective first-line agent in combination with standard analgesic and antiemetic agents for the treatment of gastroparesis in the emergency department.
Two federal environmental standards regulating lead hazards in homes and child care facilities have different maximum thresholds, a discrepancy putting more than 35,000 kids in the United States at increased risk of lead poisoning.
Case Western Reserve University and Q2 Pharma Ltd., an Israeli biopharmaceutical company, have signed a two-year option to license small molecule, antivirulence technology to potentially treat bacterial infections such as methicillin-resistant staphylococcus aureus (MRSA), the first known scientific effort of its kind.
Monash University researchers have gained new insight into the early stages of our immune response, providing novel pathways to develop treatments for diseases from multiple sclerosis to cancer.
› Verified 7 days ago
| Provider Name | Athletico Ltd |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1821085028 PECOS PAC ID: 4789602681 Enrollment ID: O20120612000342 |
News Archive
Seattle scientists from Cure First, a non-profit research organization, and SEngine Precision Medicine, a biotech developing targeted, more effective, and less toxic cancer therapeutics, co-authored one of 27 high-profile papers published today by Cell Press.
Haloperidol is an effective first-line agent in combination with standard analgesic and antiemetic agents for the treatment of gastroparesis in the emergency department.
Two federal environmental standards regulating lead hazards in homes and child care facilities have different maximum thresholds, a discrepancy putting more than 35,000 kids in the United States at increased risk of lead poisoning.
Case Western Reserve University and Q2 Pharma Ltd., an Israeli biopharmaceutical company, have signed a two-year option to license small molecule, antivirulence technology to potentially treat bacterial infections such as methicillin-resistant staphylococcus aureus (MRSA), the first known scientific effort of its kind.
Monash University researchers have gained new insight into the early stages of our immune response, providing novel pathways to develop treatments for diseases from multiple sclerosis to cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Johnson, DPT 625 Enterprise Dr., Oak Brook, IL 60523-8813 Ph: (630) 575-6250 | Melissa Johnson, DPT 1776 W Centennial Pl, 2nd Floor, Addison, IL 60101-1075 Ph: (630) 953-0343 |
News Archive
Seattle scientists from Cure First, a non-profit research organization, and SEngine Precision Medicine, a biotech developing targeted, more effective, and less toxic cancer therapeutics, co-authored one of 27 high-profile papers published today by Cell Press.
Haloperidol is an effective first-line agent in combination with standard analgesic and antiemetic agents for the treatment of gastroparesis in the emergency department.
Two federal environmental standards regulating lead hazards in homes and child care facilities have different maximum thresholds, a discrepancy putting more than 35,000 kids in the United States at increased risk of lead poisoning.
Case Western Reserve University and Q2 Pharma Ltd., an Israeli biopharmaceutical company, have signed a two-year option to license small molecule, antivirulence technology to potentially treat bacterial infections such as methicillin-resistant staphylococcus aureus (MRSA), the first known scientific effort of its kind.
Monash University researchers have gained new insight into the early stages of our immune response, providing novel pathways to develop treatments for diseases from multiple sclerosis to cancer.
› Verified 7 days ago
Dr. Timothy Robert Gibbons, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1841 W Army Trail Rd, Addison, IL 60101 Phone: 630-238-9235 | |
Jennifer Alcedo, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2171 W Executive Dr Ste 500, Addison, IL 60101 Phone: 630-766-0505 Fax: 630-766-0855 | |
Crystal Wright, PTA Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2171 W Executive Dr Ste 500, Addison, IL 60101 Phone: 630-766-0505 | |
Marzena D Kaniuk, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1415 W Lake St, Addison, IL 60101 Phone: 866-644-8040 Fax: 630-705-1980 | |
Adam E Brhel, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1776 W Centennial Pl, Addison, IL 60101 Phone: 630-953-0343 Fax: 630-953-0353 | |
Jane Soo Eun, MPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 500 W Lake St, Addison, IL 60101 Phone: 630-607-1820 Fax: 630-628-5307 | |
Gazanfer Mushtaq, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1776 W Centennial Pl, Addison, IL 60101 Phone: 630-953-0343 Fax: 630-953-0353 |